These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8132181)

  • 1. Committees on Toxicity, Mutagenicity and Carcinogenicity.
    Food Chem Toxicol; 1994 Feb; 32(2):198-200. PubMed ID: 8132181
    [No Abstract]   [Full Text] [Related]  

  • 2. Committees on toxicity, mutagenicity and carcinogenicity.
    Food Chem Toxicol; 1995 Apr; 33(4):333-5. PubMed ID: 7737608
    [No Abstract]   [Full Text] [Related]  

  • 3. The expanding role of predictive toxicology: an update on the (Q)SAR models for mutagens and carcinogens.
    Benigni R; Netzeva TI; Benfenati E; Bossa C; Franke R; Helma C; Hulzebos E; Marchant C; Richard A; Woo YT; Yang C
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(1):53-97. PubMed ID: 17365342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of chemical carcinogenicity and mutagenicity: a review with implications for predictive toxicology.
    Benigni R; Bossa C
    Chem Rev; 2011 Apr; 111(4):2507-36. PubMed ID: 21265518
    [No Abstract]   [Full Text] [Related]  

  • 5. Summary of the National Toxicology Program benzidine dye initiative.
    Morgan DL; Dunnick JK; Goehl T; Jokinen MP; Matthews HB; Zeiger E; Mennear JH
    Environ Health Perspect; 1994 Jun; 102 Suppl 2(Suppl 2):63-78. PubMed ID: 7925189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A synopsis of the Third International Federation of Societies of Toxicologic Pathologists conference.
    Tryphonas L; Gopinath C
    Toxicol Pathol; 2000; 28(3):370-4. PubMed ID: 10862552
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessment of predictivity of volatile organic compounds carcinogenicity and mutagenicity by freeware in silico models.
    Guerra LR; de Souza AMT; Côrtes JA; Lione VOF; Castro HC; Alves GG
    Regul Toxicol Pharmacol; 2017 Dec; 91():1-8. PubMed ID: 28970106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships for the mutagenicity and carcinogenicity of simple and alpha-beta unsaturated aldehydes.
    Benigni R; Passerini L; Rodomonte A
    Environ Mol Mutagen; 2003; 42(3):136-43. PubMed ID: 14556221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term tests for defining mutagenic carcinogens.
    Waters MD; Stack HF; Jackson MA
    IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternatives to the carcinogenicity bioassay for toxicity prediction: are we there yet?
    Benigni R
    Expert Opin Drug Metab Toxicol; 2012 Apr; 8(4):407-17. PubMed ID: 22360376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotoxicity and carcinogenicity of metronidazole.
    Dobiás L; Cerná M; Rössner P; Srám R
    Mutat Res; 1994 Jun; 317(3):177-94. PubMed ID: 7515153
    [No Abstract]   [Full Text] [Related]  

  • 12. Structure-activity relations: maximizing the usefulness of mutagenicity and carcinogenicity databases.
    Klopman G; Rosenkranz H
    Environ Health Perspect; 1991 Dec; 96():67-75. PubMed ID: 1820281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mutagenicity an carcinogenicity of aflatoxin AFB1].
    Pierzynowska J; Grzesiuk E
    Postepy Biochem; 1999; 45(4):313-9. PubMed ID: 10786375
    [No Abstract]   [Full Text] [Related]  

  • 14. The OSIRIS Weight of Evidence approach: ITS mutagenicity and ITS carcinogenicity.
    Buist H; Aldenberg T; Batke M; Escher S; Klein Entink R; Kühne R; Marquart H; Pauné E; Rorije E; Schüürmann G; Kroese D
    Regul Toxicol Pharmacol; 2013 Nov; 67(2):170-81. PubMed ID: 23357514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenicity testing: its elusive quantiation.
    Di Carlo FJ
    Drug Metab Rev; 1979; 9(2):v-vi. PubMed ID: 487938
    [No Abstract]   [Full Text] [Related]  

  • 16. A review of current toxicological concerns on vanadium pentoxide and other vanadium compounds: gaps in knowledge and directions for future research.
    Assem FL; Levy LS
    J Toxicol Environ Health B Crit Rev; 2009 Apr; 12(4):289-306. PubMed ID: 20183524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotoxicity and carcinogenicity studies of bronchodilators and antiasthma drugs.
    Brambilla G; Mattioli F; Robbiano L; Martelli A
    Basic Clin Pharmacol Toxicol; 2013 May; 112(5):302-13. PubMed ID: 23374861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the Ames II and traditional Ames test responses with respect to mutagenicity, strain specificities, need for metabolism and correlation with rodent carcinogenicity.
    Kamber M; Flückiger-Isler S; Engelhardt G; Jaeckh R; Zeiger E
    Mutagenesis; 2009 Jul; 24(4):359-66. PubMed ID: 19447896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated approach to testing and assessment for predicting rodent genotoxic carcinogenicity.
    Petkov PI; Schultz TW; Donner EM; Honma M; Morita T; Hamada S; Wakata A; Mishima M; Maniwa J; Todorov M; Kaloyanova E; Kotov S; Mekenyan OG
    J Appl Toxicol; 2016 Dec; 36(12):1536-1550. PubMed ID: 27225589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinogenicity, mutagenicity and cancer preventing activities of flavonoids: a structure-system-activity relationship (SSAR) analysis.
    Das A; Wang JH; Lien EJ
    Prog Drug Res; 1994; 42():133-66. PubMed ID: 8085009
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.